JP2005508158A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508158A5 JP2005508158A5 JP2003526332A JP2003526332A JP2005508158A5 JP 2005508158 A5 JP2005508158 A5 JP 2005508158A5 JP 2003526332 A JP2003526332 A JP 2003526332A JP 2003526332 A JP2003526332 A JP 2003526332A JP 2005508158 A5 JP2005508158 A5 JP 2005508158A5
- Authority
- JP
- Japan
- Prior art keywords
- ndv
- glycoprotein
- strain
- viral
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL14539701A IL145397A0 (en) | 2001-09-12 | 2001-09-12 | Compositions and methods for treatment of cancer |
| PCT/IL2002/000765 WO2003022202A2 (en) | 2001-09-12 | 2002-09-12 | Compositions and methods for treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508158A JP2005508158A (ja) | 2005-03-31 |
| JP2005508158A5 true JP2005508158A5 (enExample) | 2006-01-05 |
Family
ID=11075779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526332A Pending JP2005508158A (ja) | 2001-09-12 | 2002-09-12 | 癌治療のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7223389B2 (enExample) |
| EP (1) | EP1424897A4 (enExample) |
| JP (1) | JP2005508158A (enExample) |
| AU (1) | AU2002341356B2 (enExample) |
| CA (1) | CA2458543A1 (enExample) |
| IL (1) | IL145397A0 (enExample) |
| WO (1) | WO2003022202A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2819185A1 (fr) * | 2001-01-08 | 2002-07-12 | Oreal | Composition cosmetique de texture pateuse a pulverulente et son utilisation en cosmetique |
| CN1946421B (zh) | 2004-04-27 | 2013-07-17 | 威尔斯达特生物制剂公司 | 使用病毒和喜树碱进行的癌症治疗 |
| NZ562951A (en) | 2005-07-14 | 2011-09-30 | Wellstat Biologics Corp | Cancer treatment using a Newcastle disease virus, a fluoropyrimidine and a camptothecin combination |
| US20090175826A1 (en) * | 2006-06-05 | 2009-07-09 | Elankumaran Subbiah | Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same |
| US20100297072A1 (en) * | 2009-05-19 | 2010-11-25 | Depinho Ronald A | Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy |
| ES2380289T3 (es) | 2009-11-30 | 2012-05-10 | United Cancer Research Institute | Nuevo clon del virus de la enfermedad de Newcastle, su fabricación y aplicación en el tratamiento médico del cáncer |
| CN102782475A (zh) * | 2009-12-14 | 2012-11-14 | 新加坡科技研究局 | 检测器模块、检测器模块的控制方法以及检测系统 |
| RU2482129C2 (ru) * | 2010-11-11 | 2013-05-20 | Никита Юрьевич Силко | Штамм вируса болезни ньюкасла для создания на его основе кандидатного противоракового препарата и изучения механизмов онколизиса |
| WO2014011072A1 (ru) * | 2012-07-11 | 2014-01-16 | Zabelin Vladimir Arkad Evich | Штамм-продуцент вируса болезни ньюкасла ndv/anas crecca/omsk/9/2010, используемый для создания на его основе кандидатного противоракового препарата |
| US10155991B2 (en) * | 2013-08-15 | 2018-12-18 | Xueliang James Xia | Biomarkers for use in colorectal cancer |
| RU2562115C1 (ru) * | 2014-11-13 | 2015-09-10 | Федеральное государственное автономное образовательное учреждение высшего образования "Новосибирский национальный исследовательский государственный университет"(Новосибирский государственный университет, НГУ) | Штамм вируса болезни ньюкасла для изучения онколитических свойств и механизмов онколизиса для создания прототипного противоопухолевого препарата |
| CN106868130B (zh) * | 2014-12-24 | 2021-03-12 | 北京丽阳吉诺科技有限公司 | 用于结肠直肠癌中使用的生物标志物 |
| JOP20190256A1 (ar) | 2017-05-12 | 2019-10-28 | Icahn School Med Mount Sinai | فيروسات داء نيوكاسل واستخداماتها |
| WO2020037215A1 (en) | 2018-08-17 | 2020-02-20 | Icahn School Of Medicine At Mount Sinai | Recombinant newcastle disease viruses and uses thereof for the prevention of rsv disease or human metapneumovirus disease |
| CN114774373B (zh) * | 2022-04-27 | 2024-07-05 | 北京市农林科学院 | 信鸽新城疫病毒基因工程改造弱毒株及其制备方法和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5215745A (en) * | 1988-04-27 | 1993-06-01 | United Cancer Research Institute | Method for treating viral diseases with attenuated virus |
| US5124148A (en) * | 1988-04-27 | 1992-06-23 | United Cancer Research Institute | Method for treating viral diseases with attenuated virus |
| US5118502A (en) * | 1989-06-20 | 1992-06-02 | The University Of Georgia Research Foundation, Inc. | Naturally attenuated newcastle disease vaccine and method of using the same |
| WO1992015672A1 (en) * | 1991-03-07 | 1992-09-17 | Virogenetics Corporation | Genetically engineered vaccine strain |
| US5602023A (en) * | 1992-03-24 | 1997-02-11 | Csatary; Laszlo K. | Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same |
| PT696326E (pt) | 1993-04-30 | 2003-08-29 | Wellstat Biologics Corp | Utilizacao de ndv no fabrico de um medicamento para tratamento do cancro |
| EP0770397B1 (en) * | 1995-10-18 | 2004-04-21 | Akzo Nobel N.V. | Newcastle disease virus combination vaccine |
| FR2749323B1 (fr) * | 1996-06-04 | 1998-07-10 | Pasteur Merieux Serums Vacc | Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique |
| FR2751225B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
| US20030044384A1 (en) * | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
| EP0974660A1 (en) * | 1998-06-19 | 2000-01-26 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| IL157504A0 (en) * | 2001-05-11 | 2004-03-28 | Wellstat Biologics Corp | Oncolytic virus therapy |
-
2001
- 2001-09-12 IL IL14539701A patent/IL145397A0/xx unknown
-
2002
- 2002-09-12 WO PCT/IL2002/000765 patent/WO2003022202A2/en not_active Ceased
- 2002-09-12 JP JP2003526332A patent/JP2005508158A/ja active Pending
- 2002-09-12 CA CA002458543A patent/CA2458543A1/en not_active Abandoned
- 2002-09-12 EP EP02775172A patent/EP1424897A4/en not_active Withdrawn
- 2002-09-12 AU AU2002341356A patent/AU2002341356B2/en not_active Ceased
-
2004
- 2004-03-11 US US10/800,256 patent/US7223389B2/en not_active Expired - Lifetime
-
2009
- 2009-10-16 US US12/580,722 patent/US20100113335A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023530229A5 (enExample) | ||
| US20220202934A1 (en) | Respiratory virus nucleic acid vaccines | |
| JP7141063B2 (ja) | 抗原およびアジュバントとしてのインターロイキン－２１を有するワクチン | |
| JP2021121638A5 (enExample) | ||
| CN1225685A (zh) | 禽多核苷酸疫苗制剂 | |
| RU2012107671A (ru) | Композиция для лечения инфекции вирусом гепатита в | |
| JP2013501038A5 (enExample) | ||
| JP2016128513A5 (enExample) | ||
| RU2011122615A (ru) | Живой аттенуированный респираторно-синцитиальный вирус | |
| CN105518129B (zh) | 减毒流感疫苗和其用途 | |
| JP2022530824A5 (enExample) | ||
| JP2024180560A5 (enExample) | ||
| Kawano et al. | Sequence determination of the hemagglutinin-neuraminidase (HN) gene of human parainfluenza type 2 virus and the construction of a phylogenetic tree for HN proteins of all the paramyxoviruses that are infectious to humans | |
| JP2004531242A5 (enExample) | ||
| JP2023536570A5 (enExample) | ||
| JP2023535163A5 (enExample) | ||
| JP2023527791A5 (enExample) | ||
| JP2003503355A5 (enExample) | ||
| JP2023527083A5 (enExample) | ||
| JP2014527526A5 (enExample) | ||
| CN103215308A (zh) | 表达重组人fviii的整合质粒、细胞株及其构建方法和应用 | |
| KR20120139657A (ko) | 파라믹소바이러스 벡터를 사용한 비강내 분무형 결핵 백신 | |
| US20140271564A1 (en) | Vesicular stomatitis viruses containing a maraba virus glycoprotein polypeptide | |
| CN103316357B (zh) | 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法 | |
| CA2597317C (en) | Uses of recombinant super-compound interferons |